02.12.2016 Views

Journal Thoracic Oncology

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

WCLC2016-Abstract-Book_vF-WEB_revNov17-1

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Abstracts <strong>Journal</strong> of <strong>Thoracic</strong> <strong>Oncology</strong> • Volume 12 Issue S1 January 2017<br />

and virtual media has the potential to bring consistency and uniformity in<br />

diagnosing patients with NSCLC, who are likely to benefit from targeted<br />

therapies. Finally, improvements in efficiency and TAT will inform physicians<br />

on management decisions without any unwarranted delays.<br />

Keywords: liquid biopsy, Molecular testing algorithms, targeted sequencing,<br />

virtual reality<br />

POSTER SESSION 2 – P2.06: SCIENTIFIC CO-OPERATION/RESEARCH GROUPS<br />

LAB, OTHER –<br />

TUESDAY, DECEMBER 6, 2016<br />

P2.06-047 LRRK2-IN-1 INHIBIT PROLIFERATION OF DOUBLECORTIN<br />

AND CAM KINASE-LIKE-1 (DCLK1)-POSITIVE LUNG CANCER CELLS<br />

Hiroyuki Tao, Yuka Mimura-Kimura, Yusuke Mimura, Akio Hara, Daigo<br />

Murakami, Masashi Furukawa, Masataro Hayashi, Kazunori Okabe<br />

Yamaguchi Ube Medical Center, Ube/Japan<br />

Background: Doublecortin and CaM kinase-like-1 (DCLK1) is a kinase that<br />

regulates microtubule polymerization in migrating neurons. DCLK1 is also<br />

suggested to be a tumor stem cell marker in colon and pancreatic cancer.<br />

The expression status of DCLK1 and its role in lung cancer remain largely<br />

unknown. LRRK2-IN-1, a potent therapeutic agent for the treatment of<br />

Parkinson’s disease, has shown to inhibit DCLK1 kinase activity. Methods:<br />

DCLK1 expression status in human non-small cell lung cancer (NSCLC) cell<br />

lines was examined by quantitative real-time RT-PCR and western blotting.<br />

Cell proliferation assay was made after treatments with either si-DCLK1 or<br />

LRRK2-IN-1. Results: DCLK1 was expressed in most of the cell lines examined<br />

in various degrees. In DCLK1-expressing cell lines, si-DCLK1 treatment showed<br />

growth inhibition. LRRK2-IN-1 treatment also showed growth inhibition, in<br />

a dose-dependent manner. Conclusion: DCLK1 can be a target molecule for<br />

NSCLC treatment. LRRK2-IN-1 might be therapeutic for DCLK1-expressing lung<br />

cancer, through inhibition of its kinase activity.<br />

Keywords: Targeted therapy, Doublecortin and CaM kinase-like-1 (DCLK1),<br />

LRRK2-IN-1<br />

POSTER SESSION 2 – P2.07: NURSES<br />

INFORMATION FOR PATIENTS –<br />

TUESDAY, DECEMBER 6, 2016<br />

constructs were companion control, companion agenda and companion<br />

as expert. Companions with a non-negotiated presence were powerful<br />

and expert and moderated information exchange. Conclusion: Companion<br />

accompaniment to lung cancer clinics if often a negotiated process and one<br />

that patients may not have total autonomy over. Accompanying companions<br />

can influence the exchange of clinical information in both a mediating and<br />

moderating manner. The level of negotiated companion presence at lung<br />

cancer consultations has clinical implications that require policy, professional<br />

and patient attention. In order to facilitate the delivery of patient-centred<br />

care and communication healthcare professionals should be aware of and<br />

respect patient preference for companion accompaniment and involvement<br />

when policy initiatives often recommend companion presence during cancer<br />

consultations.<br />

Keywords: mediating and moderating influence, information-exchange, nonnegotiated<br />

accompaniment, clinical consultations<br />

POSTER SESSION 2 – P2.07: NURSES<br />

INFORMATION FOR PATIENTS –<br />

TUESDAY, DECEMBER 6, 2016<br />

P2.07-002 EVALUATION OF PROVIDING HEALTHCARE<br />

INFORMATION FOR LUNG MASS PATIENTS AFTER SURGERY<br />

Daowan Khunyotying 1 , Ladarat Sapinun 1 , Pimpitcha Ratniyom 1 , Somcharoen<br />

Saeteng 2<br />

1 Nursing Service, Chiang Mai University, Chiang Mai/Thailand, 2 Surgery, Chiang Mai<br />

University, Chiang Mai/Thailand<br />

Background: Providing healthcare information is very important for lung mass<br />

patients after lung surgery for achieving good post-operative rehabilitation,<br />

understanding their disease, taking medication, adjusting daily life activity<br />

such as stop smoking, and health promotion. The aim of this study is to<br />

evaluate the providing healthcare information (HI) from physicians or nurses<br />

to patients before discharged and to explore the adding discharge<br />

information needs of patients. Methods: Descriptive research with<br />

prospective data collection design was conducted. All lung mass patients<br />

undergoing lung surgery at General <strong>Thoracic</strong> Surgery Unit, Department of<br />

Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand<br />

during April 1 st , 2015 to July 1 st , 2016 were enrolled in this study. Lung<br />

Information Needs Questionnaire: Thai translation was provided to patients<br />

on the day before discharge date. Results:<br />

P2.07-001 NON-NEGOTIATED COMPANION INFLUENCE<br />

ON INFORMATION EXCHANGE AT LUNG CANCER CLINIC<br />

CONSULTATIONS<br />

Allison Smith 1 , Carol Bugge 2 , Katherine Niven 2<br />

1 Greater Glasgow and Clyde Health Board, Glasgow/United Kingdom, 2 Department<br />

of Nursing and Midwifery, University of Stirling, Stirling/United Kingdom<br />

Background: Effective information exchange is an asset to effective cancer<br />

care (Thorne et al, 2005). Lung cancer is a disease with many biomedical,<br />

physical and psychological consequences. This underlines the need for<br />

patient-centred care, tailoring communication to the specific needs,<br />

values and information preferences of each individual (Kissane et al, 2010).<br />

In the context of patient-centred care, communication with healthcare<br />

professionals can impact the effectiveness of the clinical encounter and<br />

influence clinical outcomes for patients with cancer (Aiello et al, 2008).<br />

However, the way in which healthcare professionals exchange information<br />

with patients can be affected by wide-ranging, external factors. The presence<br />

and involvement of a companion can increase the challenge and complexity<br />

of information exchange during cancer consultations (Albrecht et al, 2010).<br />

Companions add extraordinary dynamics to the clinical interaction and their<br />

potential to influence the exchange, either in a mediating or moderating<br />

manner warrants further investigation. As patients with lung cancer are<br />

commonly accompanied to the consultation by companions and as national<br />

and international policies advocate accompaniment, research in this area<br />

is germane. Methods: Qualitative, multiple case study design. Each case<br />

centred on a patient with lung cancer. It included health professionals<br />

patients consulted with and any accompanying companion(s). Seven cases<br />

were recruited, including 12 companions, and six professionals. Participants<br />

were recruited in 2010-2011 at outpatient clinics. Data were: consultation<br />

recordings, debrief interviews immediately post-consultation and later<br />

in-depth patient (possibly with companion) interviews. Analysis followed<br />

case study pattern matching and coding traditions. Results: Each patient<br />

was accompanied by at least one companion. Three levels of negotiated<br />

companion accompaniment were identified: reciprocal/mutually agreed,<br />

partially negotiated/coerced and non-negotiated. Companions mediated<br />

and moderated information exchange across six major constructs. Mediating<br />

constructs were physical, emotional and informational, and moderating<br />

There were 56 patients enrolled in this study including 18 women and 38 men.<br />

The mean age was 59.16 years (SD= 13.64). The percentage of the physicians or<br />

Copyright © 2016 by the International Association for the Study of Lung Cancer<br />

S577

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!